Categories: DevelopmentDrugMedtechPlatform
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.09.2024 | - | $29M | - |
Mentions in press and media 4
| Date | Title | Description |
| 28.09.2024 | CPTx: A New Dawn in Antiviral Innovation | In the ever-evolving landscape of biotechnology, CPTx emerges as a beacon of hope. This innovative startup has recently secured $29 million in funding, a significant boost that promises to reshape the future of antiviral therapies. With a f... |
| 27.09.2024 | CPTx: Biotech Company Raises $29 Million To Develop Antiviral And Biodefense Solutions | CPTx, an innovative biotech startup committed to pioneering next-generation preventative and therapeutic solutions, announced it has raised $29 million from a diverse group of public and private investors. This funding round was led by Blue... |
| 12.09.2024 | CPTx Secures $29 Million to Advance Breakthrough Antiviral Platform | Funding builds on 15 Years of Transformative Research in Programmable DNA Nanofabrication
We are excited to have the support of such distinguished investors as we push the boundaries of antiviral therapy and expand the horizons of therapeut... |
| - | CPTx | “At CPTx, we develop new treatment paradigms across outsized medical challenges, with an initial focus on infectious diseases. The flexibility and precision of CPTx's platform supports multivalent drug development, which is crucial for addr... |
Reviews 0
